These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 17476684

  • 1. Adenosine A2A receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease.
    Pinna A, Pontis S, Borsini F, Morelli M.
    Synapse; 2007 Aug; 61(8):606-14. PubMed ID: 17476684
    [Abstract] [Full Text] [Related]

  • 2. A new ethyladenine antagonist of adenosine A(2A) receptors: behavioral and biochemical characterization as an antiparkinsonian drug.
    Pinna A, Tronci E, Schintu N, Simola N, Volpini R, Pontis S, Cristalli G, Morelli M.
    Neuropharmacology; 2010 Mar; 58(3):613-23. PubMed ID: 19951715
    [Abstract] [Full Text] [Related]

  • 3. Motor stimulant effects of the adenosine A2A receptor antagonist SCH 58261 do not develop tolerance after repeated treatments in 6-hydroxydopamine-lesioned rats.
    Pinna A, Fenu S, Morelli M.
    Synapse; 2001 Mar 01; 39(3):233-8. PubMed ID: 11284438
    [Abstract] [Full Text] [Related]

  • 4. The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets.
    Rose S, Jackson MJ, Smith LA, Stockwell K, Johnson L, Carminati P, Jenner P.
    Eur J Pharmacol; 2006 Sep 28; 546(1-3):82-7. PubMed ID: 16925991
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
    Agnati LF, Leo G, Vergoni AV, Martínez E, Hockemeyer J, Lluis C, Franco R, Fuxe K, Ferré S.
    Brain Res Bull; 2004 Aug 30; 64(2):155-64. PubMed ID: 15342103
    [Abstract] [Full Text] [Related]

  • 6. The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of l-dopa in unilaterally 6-OHDA-lesioned rats.
    Rose S, Ramsay Croft N, Jenner P.
    Brain Res; 2007 Feb 16; 1133(1):110-4. PubMed ID: 17196564
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.
    Tronci E, Simola N, Borsini F, Schintu N, Frau L, Carminati P, Morelli M.
    Eur J Pharmacol; 2007 Jul 02; 566(1-3):94-102. PubMed ID: 17445798
    [Abstract] [Full Text] [Related]

  • 8. New adenosine A2A receptor antagonists: actions on Parkinson's disease models.
    Pinna A, Volpini R, Cristalli G, Morelli M.
    Eur J Pharmacol; 2005 Apr 11; 512(2-3):157-64. PubMed ID: 15840400
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.
    Carta AR, Pinna A, Cauli O, Morelli M.
    Synapse; 2002 Jun 01; 44(3):166-74. PubMed ID: 11954048
    [Abstract] [Full Text] [Related]

  • 10. Synergistic effect of SCH 58261, an adenosine A2A receptor antagonist, and L-DOPA on the reserpine-induced muscle rigidity in rats.
    Wardas J.
    Pol J Pharmacol; 2003 Jun 01; 55(2):155-64. PubMed ID: 12926542
    [Abstract] [Full Text] [Related]

  • 11. Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists.
    Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M.
    Synapse; 2008 May 01; 62(5):345-51. PubMed ID: 18297692
    [Abstract] [Full Text] [Related]

  • 12. SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.
    Wardas J, Konieczny J, Lorenc-Koci E.
    Synapse; 2001 Aug 01; 41(2):160-71. PubMed ID: 11400182
    [Abstract] [Full Text] [Related]

  • 13. Prevention of dyskinesia by an NMDA receptor antagonist in MPTP monkeys: effect on adenosine A2A receptors.
    Morissette M, Dridi M, Calon F, Hadj Tahar A, Meltzer LT, Bédard PJ, Di Paolo T.
    Synapse; 2006 Sep 01; 60(3):239-50. PubMed ID: 16739115
    [Abstract] [Full Text] [Related]

  • 14. Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications.
    Morelli M, Di Paolo T, Wardas J, Calon F, Xiao D, Schwarzschild MA.
    Prog Neurobiol; 2007 Dec 01; 83(5):293-309. PubMed ID: 17826884
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.